Procter & Gamble Hygiene & Health Care Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is -5.20% vs -0.90% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -1.90% vs 1.12% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 4.13% vs -18.52% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is -46.10% vs -74.26% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of P&G Hygiene With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

937.67

1,781.16

-843.49

-47.36%

Other Operating Income

3.65

11.68

-8.03

-68.75%

Total Operating income

941.32

1,792.84

-851.52

-47.50%

Raw Material Cost

170.68

471.18

-300.50

-63.78%

Purchase of Finished goods

193.24

732.76

-539.52

-73.63%

(Increase) / Decrease In Stocks

-7.11

-324.17

317.06

97.81%

Employee Cost

56.53

106.28

-49.75

-46.81%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

132.54

0.00

132.54

Other Expenses

177.13

234.51

-57.38

-24.47%

Total Expenditure (Excl Depreciation)

723.01

1,220.56

-497.55

-40.76%

Operating Profit (PBDIT) excl Other Income

218.31

572.28

-353.97

-61.85%

Other Income

12.47

96.52

-84.05

-87.08%

Operating Profit (PBDIT)

230.78

668.80

-438.02

-65.49%

Interest

3.11

2.98

0.13

4.36%

Exceptional Items

0.00

0.70

-0.70

-100.00%

Gross Profit (PBDT)

227.67

665.82

-438.15

-65.81%

Depreciation

9.56

31.53

-21.97

-69.68%

Profit Before Tax

218.11

634.29

-416.18

-65.61%

Tax

64.98

150.54

-85.56

-56.84%

Provisions and contingencies

0.00

Profit After Tax

153.13

483.75

-330.62

-68.35%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

0.70

-0.70

-100.00%

Net Profit

153.13

484.45

-331.32

-68.39%

Equity Capital

32.46

31.20

1.26

4.04%

Face Value

10.00

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

47.17

31.05

16.12

51.92%

Diluted Earnings per share

47.17

31.02

16.15

52.06%

Operating Profit Margin (Excl OI)

23.28%

32.13%

0.00

-8.85%

Gross Profit Margin

24.28%

37.38%

0.00

-13.10%

PAT Margin

16.33%

27.16%

0.00

-10.83%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 937.67 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -25.58% vs 9.67% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -5.20% vs -0.90% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 153.13 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -49.20% vs 43.65% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -1.90% vs 1.12% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 218.31 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -45.67% vs 41.10% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 4.13% vs -18.52% in Mar 2025

Quarterly - Interest

Interest 3.11 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 16.48% vs -25.83% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -46.10% vs -74.26% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 23.28%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025